Header Logo

Search Results (33)

More Search Options
MatchTypeWhy
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.Academic Article Why?
Saygin, DidemPerson Why?
Pollack, MarkPerson Why?
Bennett, DavidPerson Why?
Barnes, LisaPerson Why?
Landay, AlanPerson Why?
Singh, AjaypalPerson Why?
Della Valle, CraigPerson Why?
Bonomi, PhilipPerson Why?
Singh, KernPerson Why?
Wilson, RobertPerson Why?
Cole, BrianPerson Why?
Leurgans, SuePerson Why?
Forsythe, BrianPerson Why?
Verma, NikhilPerson Why?
Per Page    Page  of 3last Nextnext
Prev
Search Criteria
  • Immune
  • related
  • adverse
  • events
Filter by Type
_
Click "Why?" to see why an item matched the search.